First Citizens Bank & Trust CO Edwards Lifesciences Corp Transaction History

First Citizens Bank & Trust CO

$6.53 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	SELL	$84.3 - $94.31 $5,058 - $5,658	-60 Reduced 1.76%	3,340 $308,000
Q1 2024 Apr 15, 2024	SELL	$72.54 - $95.56 $18,135 - $23,890	-250 Reduced 6.85%	3,400 $324,000
Q4 2023 Jan 22, 2024	SELL	$61.71 - $77.76 $160,322 - $202,020	-2,598 Reduced 41.58%	3,650 $278,000
Q3 2023 Oct 30, 2023	BUY	$69.28 - $93.38 $6,997 - $9,431	101 Added 1.64%	6,248 $432,000
Q2 2023 Aug 15, 2023	BUY	$81.41 - $94.33 $12,374 - $14,338	152 Added 2.54%	6,147 $579,000
Q1 2023 May 11, 2023	SELL	$74.26 - $84.51 $4,084 - $4,648	-55 Reduced 0.91%	5,995 $495,000
Q4 2022 Jan 24, 2023	SELL	$68.3 - $87.44 $193,972 - $248,329	-2,840 Reduced 31.95%	6,050 $452,000
Q3 2022 Oct 20, 2022	BUY	$82.37 - $107.29 $185,167 - $241,187	2,248 Added 33.85%	8,890 $735,000
Q2 2022 Jul 26, 2022	SELL	$86.5 - $128.27 $7,266 - $10,774	-84 Reduced 1.25%	6,642 $632,000
Q1 2022 Apr 26, 2022	BUY	$101.96 - $128.34 $37,011 - $46,587	363 Added 5.7%	6,726 $792,000
Q4 2021 Mar 11, 2022	SELL	$106.37 - $130.68 $9,254 - $11,369	-87 Reduced 1.35%	6,363 $824,000
Q3 2021 Oct 15, 2021	SELL	$102.91 - $122.75 $151,174 - $180,319	-1,469 Reduced 18.55%	6,450 $730,000
Q2 2021 Jul 14, 2021	SELL	$83.84 - $104.76 $2,012 - $2,514	-24 Reduced 0.3%	7,919 $820,000
Q1 2021 Apr 14, 2021	BUY	$78.68 - $90.67 $32,809 - $37,809	417 Added 5.54%	7,943 $664,000
Q4 2020 Jan 13, 2021	BUY	$71.69 - $91.23 $38,640 - $49,172	539 Added 7.71%	7,526 $687,000
Q3 2020 Oct 15, 2020	SELL	$67.19 - $87.44 $5,039 - $6,558	-75 Reduced 1.06%	6,987 $558,000
Q2 2020 Jul 15, 2020	BUY	$57.54 - $76.95 $252,312 - $337,425	4,385 Added 163.8%	7,062 $488,000
Q1 2020 Apr 17, 2020	SELL	$52.41 - $81.0 $11,897 - $18,387	-227 Reduced 7.82%	2,677 $505,000
Q3 2019 Oct 18, 2019	SELL	$61.55 - $75.43 $5,047 - $6,185	-82 Reduced 2.75%	2,904 $639,000
Q2 2019 Jul 11, 2019	SELL	$55.74 - $64.41 $50,500 - $58,355	-906 Reduced 23.28%	2,986 $551,000
Q1 2019 Apr 12, 2019	SELL	$47.89 - $64.05 $2,442 - $3,266	-51 Reduced 1.29%	3,892 $745,000
Q4 2018 Jan 15, 2019	BUY	$46.41 - $56.94 $2,459 - $3,017	53 Added 1.36%	3,943 $604,000
Q3 2018 Oct 18, 2018	SELL	$45.7 - $58.03 $274 - $348	-6 Reduced 0.15%	3,890 $677,000
Q2 2018 Jul 11, 2018	BUY	$42.45 - $51.3 $34,809 - $42,066	820 Added 26.66%	3,896 $567,000
Q1 2018 Apr 11, 2018	BUY	$37.19 - $47.45 $4,388 - $5,599	118 Added 3.99%	3,076 $429,000
Q4 2017 Jan 10, 2018	SELL	$33.79 - $39.39 $211,221 - $246,226	-6,251 Reduced 67.88%	2,958 $333,000
Q3 2017 Oct 12, 2017	BUY	$36.29 - $38.83 $334,194 - $357,585	9,209	9,209 $1.01 Million

Others Institutions Holding EW

# of Institutions

1,351

Shares Held

455M

Call Options Held

9.76M

Put Options Held

3.92M

Vanguard Group Inc Valley Forge, PA

62.6M
Shares

$4.24 Billion
0.08% of portfolio
Black Rock Inc. New York, NY

51M
Shares

$3.45 Billion
0.11% of portfolio
Wellington Management Group LLP Boston, MA

31.5M
Shares

$2.14 Billion
0.37% of portfolio
State Street Corp Boston, MA

26.3M
Shares

$1.78 Billion
0.07% of portfolio
Geode Capital Management, LLC Boston, MA

13.5M
Shares

$916 Million
0.07% of portfolio

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Citizens Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on First Citizens Bank & Trust CO with notifications on news.

Account